Public Service Enterprise Group Inc. Stock Advances 4.4%, Outperforms Peers
Dow Jones2026/10/06 20:34This article was automatically generated by Dow Jones using technology from Automated Insights. Shares of Public Service Enterprise Group Inc. rallied 4.4% to $71.73 on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.6% to 7,818.93 and the Dow Jones Industrial Average rising 0.5% to 51,521.28. This was the stock's fourth consecutive day of gains. Public Service Enterprise Group Inc. closed 18.1% short of its 52-week high of $87.63, which the company achieved on February 26th. The stock outperformed some of its peers, as Duke Energy Corp. rose 1.6% to $115.66, Exelon Corp. rose 2.1% to $41.68, and Sempra rose 2.32% to $79.97. Trading volume totaled 8.8 million, compared to the 50-day average of 3.2 million. Data source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires October 06, 2026 16:34 ET (20:34 GMT)
This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Public Service Enterprise Group Inc. rallied 4.4% to $71.73 on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.6% to 7,818.93 and the Dow Jones Industrial Average rising 0.5% to 51,521.28.
This was the stock's fourth consecutive day of gains.
Public Service Enterprise Group Inc. closed 18.1% short of its 52-week high of $87.63, which the company achieved on February 26th.
The stock outperformed some of its peers, as Duke Energy Corp. rose 1.6% to $115.66, Exelon Corp. rose 2.1% to $41.68, and Sempra rose 2.32% to $79.97.
Trading volume totaled 8.8 million, compared to the 50-day average of 3.2 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 06, 2026 16:34 ET (20:34 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Gold Price Forecast: XAU/USD retraces gains and nears two-month lows at $4,104
BUZZ-Caribou shares plunge as company explores sale and cancels cancer project
October 7 - ** Caribou Biosciences (CRBU.O) shares fell 35.9% in pre-market trading to $0.72 ** Caribou Biosciences announced late Tuesday that it is exploring strategic options, including a potential sale, merger, or other transactions, to maximize shareholder value ** Caribou said it plans to halt development of its allogeneic CAR-T cell therapy programs, including vispa-cel for non-Hodgkin lymphoma and CB-011 for multiple myeloma ** Caribou also stated it will lay off employees and cut costs, with most layoffs expected to be completed by Q4 2026 ** As of June 30, the company held $113.8 millions in cash, cash equivalents, and marketable securities ** As of the previous trading day's close, the company's share price had dropped about 28% year-to-date (Note: For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. Since automated translations may be inaccurate or lack necessary context, Reuters does not guarantee the accuracy of automated translation texts and provides them only for reader convenience. Reuters assumes no responsibility for any damages or losses resulting from the use of automated translation features.)
Australian Dollar: Neutral outlook inside tight range against US Dollar – UOB
Crypto prices
More
